Cross‐Tissue Transcriptomic and Spatial Mapping Analyses Identify Novel Non‐HLA Candidate Causal Genes for Sarcoidosis
International Journal of Clinical Practice · 2026-01 · 2026 (1)
DOI: 10.1155/ijcp/3375907 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical Practice, online erschienen am 08.07.2026. Verfasst von Hong Li und 8 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Sarcoidosis is a complex granulomatous disease with a substantial heritable component, yet its genetic basis beyond the HLA region remains largely unexplored, limiting progress toward precision therapeutics.
Methods
We performed a comprehensive multiomics analysis by leveraging genome‐wide association study (GWAS) data from the FinnGen consortium (5411 cases; 492,311 controls) and expression quantitative trait loci (eQTL) data from the GTEx v8 project across 49 tissues. Cross‐tissue transcriptome‐wide association studies (TWASs) were conducted using two complementary approaches, UTMOST and sCCA‐ACAT, followed by Bayesian colocalization and Mendelian randomization (MR) to support causal prioritization. Genetically informed spatial mapping (gsMap) was applied to spatial transcriptomics (ST) data from patient muscular sarcoidosis tissue to delineate the cellular specificity of identified genetic associations.
Results
Cross‐tissue TWAS analyses consistently identified three novel, non‐MHC susceptibility genes: RFTN2 , FAM117B , and RNF215 . Bayesian colocalization confirmed shared causal variants, and MR demonstrated that genetically predicted higher expression of RFTN2 and FAM117B was causally associated with a decreased risk of sarcoidosis, while elevated RNF215 expression was associated with an increased risk. ST mapping further localized these genetic signals to granuloma‐associated macrophage populations within patient muscular sarcoidosis tissue.
Conclusion
This study expands the genetic landscape of sarcoidosis beyond the classical HLA locus, uncovering novel susceptibility genes involved in membrane raft organization and ubiquitin‐mediated proteolysis. RFTN2 , FAM117B , and RNF215 emerge as promising candidate targets for future functional studies and therapeutic development in sarcoidosis.
Zitieren
APA
Li, H., Li, Z., Deng, Q., Wang, S., Peng, T., Zhang, J., Cai, S., Pan, W., & Ye, X. (2026). Cross‐Tissue Transcriptomic and Spatial Mapping Analyses Identify Novel Non‐HLA Candidate Causal Genes for Sarcoidosis. International Journal of Clinical Practice, 2026(1). https://doi.org/10.1155/ijcp/3375907
Vancouver
Li H, Li Z, Deng Q, Wang S, Peng T, Zhang J, et al. Cross‐Tissue Transcriptomic and Spatial Mapping Analyses Identify Novel Non‐HLA Candidate Causal Genes for Sarcoidosis. International Journal of Clinical Practice. 2026;2026(1). doi:10.1155/ijcp/3375907
BibTeX
@article{Li2026,
author = {Li, Hong and Li, Zhanqi and Deng, Qianke and Wang, Sumeng and Peng, Tingting and Zhang, Junyi and Cai, Shanshan and Pan, Wenju and Ye, Xiaoxuan},
title = {Cross‐Tissue Transcriptomic and Spatial Mapping Analyses Identify Novel Non‐HLA Candidate Causal Genes for Sarcoidosis},
journal = {International Journal of Clinical Practice},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijcp/3375907}
}
EUVIMED